X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-6-2024-62498.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-25-2023-66768.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-18-2023-33998.pdf
https://www.fiercepharma.com/pharma/novartis-isnt-done-shaking-things-sells-five-eyecare-drugs-harrow-130-million
https://www.business-standard.com/article/companies/aurobindo-sun-pharma-recall-products-in-us-market-for-defaulting-norms-122022700249_1.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-23-2022-1645600799.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-2-2022-1643778781.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-29-2021-1640749235.pdf
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Moxifloxacin+%28Moxeza%29+Ophthalmic+Solution&st=d&tab=tabs-4&panels=0
https://www.firstwordpharma.com/node/1768450?tsid=5
https://www.moneycontrol.com/news/india/coronavirus-outbreak-govt-panel-lists-essential-medicines-that-may-run-out-of-stock-report-4994821.html
https://www.biospace.com/article/releases/nabriva-to-present-data-at-the-chest-annual-meeting-demonstrating-the-safety-and-efficacy-of-newly-fda-approved-xenleta-lefamulin-for-the-treatment-of-cabp-poster-sessions-to-highlight-pooled-results-from-the-pivo/?s=95
https://www.pharmacompass.com/pdf/news/KRS-Global-Biotechnology-Issues-Voluntary-Nationwide-Recall-of-All-Human-and-Animal-Sterile-Drug-Products-1568424609.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf
https://www.pharmacompass.com/pdf/news/imprimis-njof-llc-receives-fda-warning-letter-1562735073.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-6-2019-1551846529.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-for-Week-of-February-20-2019-1550644123.pdf
https://www.nbcnews.com/health/health-news/fda-warns-some-antibiotics-can-cause-serious-heart-damage-n950606
https://www.raps.org/news-and-articles/news-articles/2018/12/aorta-tears-with-certain-antibiotic-use-fda-warns?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2021%20December
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-October-31-2018-1540974685.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-8-2018-1533711950.pdf
https://health.economictimes.indiatimes.com/news/pharma/commonly-used-antibiotic-in-india-under-usfda-lens/64958016
https://endpts.com/nabriva-goes-2-for-2-in-phase-iii-antibiotic-program-scoring-on-a-key-catalyst-and-teeing-up-an-fda-pitch-for-lefamulin/
http://phx.corporate-ir.net/phoenix.zhtml?c=253770&p=irol-newsArticle&ID=2350291
http://phx.corporate-ir.net/phoenix.zhtml?c=253770&p=irol-newsArticle&ID=2343857
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206447
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206447
https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm569123.htm
http://www.reuters.com/article/fda-cempra-approval-idUSL1N1D51V2?rpc=401
http://www.reuters.com/article/us-cempra-antibiotic-fda-idUSKBN12X1HW
http://twofourinsight.com/nppa-reverses-course-withdraws-pricing-order-fdc-moxifloxacin-prednisolone-acetate/
http://www.gmanetwork.com/news/story/510826/news/nation/fda-warns-vs-5-unregistered-drug-products
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm446283.htm
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205572Orig1s000ltr.pdf
Market Place
Share 
